ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit Press release … ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit LEIDEN, … Julho 06, 2023
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology Dezembro 22, 2022
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing Press release … Leading Intellectual Property Estate for ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, … Novembro 06, 2023
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Dezembro 22, 2022
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 Press release … ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 LEIDEN, Netherlands … Maio 09, 2023
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Press release … Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Initial pipeline … Março 29, 2023
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 Press release … Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 Platform demonstrates … Janeiro 19, 2024
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 Press release … ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide … Maio 09, 2022
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Novembro 14, 2022
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Março 14, 2023
